Featured Clinical Focus
AML
Biomarker-Driven Lung Cancer
Breast Cancer
CAR T-Cell Therapy
Chronic Lymphocytic Leukemia
EGFR+ Lung Cancer
Follicular Lymphoma
GI Cancers
HCC
HER2-Positive Breast Cancer
Lung Cancer
Lymphomas
Mantle Cell Lymphoma
MPNs
Multiple Myeloma
Prostate Cancer
Renal Cell Carcinoma
Thyroid Cancers
Clinical Focus
Brain Cancer
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Cancers
Head & Neck Cancers
Hematology
Leukemias
Lung Cancer
Lymphomas
Melanoma
Sarcoma
Skin Cancers
Thyroid Cancers
News
All News
Press Releases
Conferences
Conference Coverage
Conference Listing
Media
All Videos
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Medical World News
Podcasts
Precision Medicine
Publications
All Publications
CBPP Spotlight Live
Evolving Paradigms
Targeted Therapies in Oncology
Resources
Education
Partners
Subscribe
eNewsletter
Search
Featured Clinical Focus
AML
Biomarker-Driven Lung Cancer
Breast Cancer
CAR T-Cell Therapy
Chronic Lymphocytic Leukemia
EGFR+ Lung Cancer
Follicular Lymphoma
GI Cancers
HCC
HER2-Positive Breast Cancer
Lung Cancer
Lymphomas
Mantle Cell Lymphoma
MPNs
Multiple Myeloma
Prostate Cancer
Renal Cell Carcinoma
Thyroid Cancers
Clinical Focus
See All >
Brain Cancer
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Cancers
Head & Neck Cancers
Hematology
Leukemias
Lung Cancer
Lymphomas
Melanoma
Sarcoma
Skin Cancers
Thyroid Cancers
Clinical Cases in HER2+ Breast Cancer | Expert Perspective Tumor Board
Experts in breast oncology review 3 clinical cases of HER2+ breast cancer and discuss individualized treatment approaches for each patient.
home
EP 1: Case 1: Early Stage HER2+ Breast Cancer
EP 2: Case 1: Molecular Testing for HER2+ Breast Cancer
EP 3: Case 1: Neoadjuvant Therapy for Early-Stage HER2+ Breast Cancer
EP 4: Case 1: Choosing Therapy for Early Stage HER2+ Breast Cancer
EP 5: Case 1: Adjuvant Treatment for Residual Disease in Early Stage HER2+ Breast Cancer
EP 6: Case 1: Adjuvant Therapy After pCR in Early Stage HER2+ Breast Cancer
EP 7: Case 1: Adjuvant Trials for HER2+ Breast Cancer
EP 8: Case 1: De-Escalation of Adjuvant Anti-HER2 Therapy for Breast Cancer
EP 9: Case 1: Subcutaneous Trastuzumab-Pertuzumab for HER2+ Breast Cancer
EP 10: Case 2: Relapsed/Refractory HR-/HER2+ Breast Cancer
EP 11: Case 2: Previously Treated HER2+ Breast Cancer
EP 12: Case 2: Later-Line Treatment of HER2+ Breast Cancer
EP 13: Case 2: Impact of Brain Metastases in HER2+ Breast Cancer
EP 14: Case 2: Risk Factors for Brain Metastases in HER2+ Breast Cancer
EP 15: Case 2: Adverse Effects of Treatments for HER2+ Breast Cancer
EP 16: Case 2: Sequencing Treatments for HER2+ Breast Cancer
EP 17: Case 2: Novel Agents in Late-Stage Clinical Trials for HER2+ MBC
EP 18: Case 3: Triple-Positive Metastatic Breast Cancer
EP 19: Case 3: Distant Metastases in Triple-Positive Breast Cancer